# Banco Santander Chile: financial statements, quarterly

BSAC · NYSE · CIK 1027552 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bsac.md) · [Financials](/companies/bsac/financials.md) · [Filings](/companies/bsac/filings.md) · [Insiders](/companies/bsac/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bsac/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2014-12-31) | period not labelled (2015-12-31) | period not labelled (2016-12-31) | FY2017 (2017-12-31) | FY2018 (2018-12-31) | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [1,859](/filings/0000950103-18-003835.md) | [2,327](/filings/0001615774-19-004410.md) | [2,486](/filings/0000950103-20-004862.md) | [1,634](/filings/0000950103-21-003159.md) | [2,256](/filings/0001213900-22-009472.md) | [3,711](/filings/0001213900-23-013772.md) | [2,895](/filings/0001213900-24-015910.md) | [2,892](/filings/0001027552-25-000035.md) | [2,080](/filings/0001027552-26-000038.md) | [2,761](/filings/0001027552-26-000038.md) | [2,771](/filings/0001027552-26-000038.md) | [2,093](/filings/0001027552-26-000038.md) |
| Total assets | $bn | not reported | not reported | [37,030](/filings/0000950103-18-003835.md) | [35,824](/filings/0001615774-19-004410.md) | [39,133](/filings/0000950103-20-004862.md) | [50,575](/filings/0000950103-21-003159.md) | [55,703](/filings/0001213900-22-009472.md) | [63,842](/filings/0001213900-23-013772.md) | [68,422](/filings/0001213900-24-015910.md) | [70,782](/filings/0001027552-25-000035.md) | [68,403](/filings/0001027552-26-000038.md) | [68,147](/filings/0001027552-26-000038.md) |
| Total liabilities | $bn | not reported | not reported | [34,092](/filings/0000950103-18-003835.md) | [32,676](/filings/0001615774-19-004410.md) | [35,887](/filings/0000950103-20-004862.md) | [8,385](/filings/0000950103-21-003159.md) | [9,643](/filings/0000950103-21-003159.md) | [59,414](/filings/0001213900-23-013772.md) | [63,458](/filings/0001213900-24-015910.md) | [65,439](/filings/0001027552-25-000035.md) | [63,044](/filings/0001027552-26-000038.md) | [62,411](/filings/0001027552-26-000038.md) |
| Shareholders' equity | $bn | [2,675](/filings/0000950103-18-003835.md) | [2,803](/filings/0001615774-19-004410.md) | [2,909](/filings/0000950103-18-003835.md) | [3,106](/filings/0001615774-19-004410.md) | [3,199](/filings/0000950103-20-004862.md) | [3,399](/filings/0000950103-21-003159.md) | [3,620](/filings/0001213900-22-009472.md) | [4,333](/filings/0001213900-23-013772.md) | [4,854](/filings/0001213900-24-015910.md) | [5,218](/filings/0001027552-25-000035.md) | [5,255](/filings/0001027552-26-000038.md) | [5,616](/filings/0001027552-26-000038.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Total assets: ifrs-full:Assets
- Total liabilities: ifrs-full:Liabilities, us-gaap:Liabilities
- Shareholders' equity: ifrs-full:Equity, ifrs-full:EquityAttributableToOwnersOfParent

Shares outstanding: 188,446,126,794 at 2025-12-31, from the cover of the [20-F filed 2026-02-27](/filings/0001027552-26-000038.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:30 ET. No prices; not investment advice.